Can Procalcitonin and Other Biomarkers Help Rapidly Identify Sepsis Among Undifferentiated High-Risk Patients in the Emergency Department?

被引：1

作者：

Rhee, Chanu ^{[1
,2
]}

Filbin, Michael R. ^{[3
]}

机构：

[1] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA

[3] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA

来源：

CRITICAL CARE MEDICINE | 2024年 / 52卷 / 06期

关键词：

biomarkers; procalcitonin; quick Sequential Organ Failure Assessment; sepsis; septic shock; ANTIBIOTICS;

D O I：

10.1097/CCM.0000000000006241

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：979 / 982

页数：4

共 15 条

[1] Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review
Barichello, Tatiana
Generoso, Jaqueline S.
Singer, Mervyn
Dal-Pizzol, Felipe
[J]. CRITICAL CARE, 2022, 26 (01)
[2] Biomarkers Improve Diagnostics of Sepsis in Adult Patients With Suspected Organ Dysfunction Based on the Quick Sepsis-Related Organ Failure Assessment (qSOFA) Score in the Emergency Department
Bolanaki, Myrto
Winning, Johannes
Slagman, Anna
Lehmann, Thomas
Kiehntopf, Michael
Stacke, Angelika
Neumann, Caroline
Reinhart, Konrad
Moeckel, Martin
Bauer, Michael
[J]. CRITICAL CARE MEDICINE, 2024, 52 (06) : 887 - 899
[3] Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
Bouadma, Lila
Luyt, Charles-Edouard
Tubach, Florence
Cracco, Christophe
Alvarez, Antonio
Schwebel, Carole
Schortgen, Frederique
Lasocki, Sigismond
Veber, Benoit
Dehoux, Monique
Bernard, Maguy
Pasquet, Blandine
Regnier, Bernard
Brun-Buisson, Christian
Chastre, Jean
Wolff, Michel
[J]. LANCET, 2010, 375 (9713) : 463 - 474
[4] Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
de Jong, Evelien
van Oers, Jos A.
Beishuizen, Albertus
Vos, Piet
Vermeijden, Wytze J.
Haas, Lenneke E.
Loef, Bert G.
Dormans, Tom
van Melsen, Gertrude C.
Kluiters, Yvette C.
Kemperman, Hans
van den Elsen, Maarten J.
Schouten, Jeroen A.
Streefkerk, Joern O.
Krabbe, Hans G.
Kieft, Hans
Kluge, Georg H.
van Dam, Veerle C.
van Pelt, Joost
Bormans, Laura
Otten, Martine Bokelman
Reidinga, Auke C.
Endeman, Henrik
Twisk, Jos W.
van de Garde, Ewoudt M. W.
de Smet, Anne Marie G. A.
Kesecioglu, Jozef
Girbes, Armand R.
Nijsten, Maarten W.
de lange, Dylan W.
[J]. LANCET INFECTIOUS DISEASES, 2016, 16 (07) : 819 - 827
[5] Evans L, 2021, INTENS CARE MED, V47, P1181, DOI [10.1007/s00134-021-06506-y, 10.1097/CCM.0000000000005337]
[6] Presenting Symptoms Independently Predict Mortality in Septic Shock: Importance of a Previously Unmeasured Confounder
Filbin, Michael R.
Lynch, James
Gillingham, Trent D.
Thorsen, Jill E.
Pasakarnis, Corey L.
Nepal, Saurav
Matsushima, Minoru
Rhee, Chanu
Heldt, Thomas
Reisner, Andrew T.
[J]. CRITICAL CARE MEDICINE, 2018, 46 (10) : 1592 - 1599
[7] Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum: Real-World Utilization and Performance Characteristics, 65 US Hospitals, 2008-2017
Lawandi, Alexander
Oshiro, Marissa
Warner, Sarah
Diao, Guoqing
Strich, Jeffrey R.
Babiker, Ahmed
Rhee, Chanu
Klompas, Michael
Danner, Robert L.
Kadri, Sameer S.
[J]. CRITICAL CARE MEDICINE, 2023, 51 (11) : 1527 - 1537
[8] Miller RR, 2018, AM J RESP CRIT CARE, V198, P903, DOI [10.1164/rccm.201712-2472OC, 10.1164/rccm.201712-2472oc]
[9] O'Neal Hollis R Jr, 2021, Crit Care Explor, V3, pe0460, DOI 10.1097/CCE.0000000000000460
[10] Risk of Misleading Conclusions in Observational Studies of Time-to-Antibiotics and Mortality in Suspected Sepsis
Pak, Theodore R.
Young, Jessica
McKenna, Caroline S.
Agan, Anna
DelloStritto, Laura
Filbin, Michael R.
Dutta, Sayon
Kadri, Sameer S.
Septimus, Edward J.
Rhee, Chanu
Klompas, Michael
[J]. CLINICAL INFECTIOUS DISEASES, 2023, 77 (11) : 1534 - 1543

← 1 2 →